Bengene Life Sciences Private Limited

Pharmaceutical company manufacturing dry powder injections and other therapeutic segments.

2019 | Villupuram, Tamil Nadu (India) | Active
Last Updated: July 26, 2024

Bengene Life Sciences Profile

Key Indicators

  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 9.70 M
  • Company Age 5 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 1.45 Cr
  • Revenue Growth -33.27%
  • Profit Growth 72.39%
  • Ebitda 30.84%
  • Net Worth 34.79%
  • Total Assets 18.19%

About Bengene Life Sciences

Bengene Life Sciences Private Limited (BLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 February 2019 (Five years and 11 months 14 days old ). Its registered office is in Villupuram, Tamil Nadu, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.70 M.

The company currently has active open charges totaling ₹1.45 Cr.

Senthiladipan Venkatachalam, Perumal Shanmugam, Dhanabal Lakshmanan, and One other member serve as directors at the Company.

Company Details

  • Location

    Villupuram, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website
  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24290TN2019PTC127701

  • Company No.

    127701

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    25 Feb 2019

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chennai

Industry

Pharma

What products or services does Bengene Life Sciences Private Limited offer?

Bengene Life Sciences Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Anti Infective Drugs & Medicines, Antibiotic Injection, Antibacterial Drugs.

Who are the key members and board of directors at Bengene Life Sciences?

Board Members (4)

Name Designation Appointment Date Status
Senthiladipan Venkatachalam Country flag representing In Director 25-Feb-2019 Current
Perumal Shanmugam Country flag representing In Additional Director 30-Apr-2019 Current
Dhanabal Lakshmanan Country flag representing In Director 25-Feb-2019 Current
Ponniah Saravanaperumal Country flag representing In Director 25-Feb-2019 Current

Financial Performance of Bengene Life Sciences.

Bengene Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.27% decrease. The company also saw a substantial improvement in profitability, with a 72.39% increase in profit. The company's net worth Soared by an impressive increase of 34.79%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
-33.27%
Revenue from Operations
-33.27%
Total Assets
18.19%
Profit or Loss
72.39%
Net Worth
34.79%
EBITDA
30.84%

What is the Ownership and Shareholding Structure of Bengene Life Sciences?

In 2023, Bengene Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹1.45 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 1.45 Cr

Latest Charge Details

Date Lender Amount Status
20 Mar 2023 Others ₹4.70 M Open
03 Feb 2022 Others ₹9.80 M Open

How Many Employees Work at Bengene Life Sciences?

Unlock and access historical data on people associated with Bengene Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bengene Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bengene Life Sciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Bengene Life Sciences

Recent activity within the organization

  • Annual General Meeting

    Bengene Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Bengene Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai.

    31 Mar 2023

  • Charges

    A charge with Others amounted to Rs. 0.47 Cr with Charge ID 100710404 was registered on 20 Mar 2023.

    20 Mar 2023

  • Charges

    A charge with Others amounted to Rs. 0.98 Cr with Charge ID 100540359 was registered on 03 Feb 2022.

    03 Feb 2022

  • Director Appointment

    Perumal Shanmugam was appointed as a Additional Director was appointed as a Additional Director on 30 Apr 2019 & has been associated with this company since 5 years 9 months .

    30 Apr 2019

  • Director Appointment

    Senthiladipan Venkatachalam was appointed as a Director was appointed as a Director on 25 Feb 2019 & has been associated with this company since 5 years 11 months .

    25 Feb 2019

Frequently asked questions

  • Bengene Life Sciences Private Limited was incorporated on 25 Feb 2019.

  • The authorized share capital of Bengene Life Sciences Private Limited is ₹ 1.00 Cr and paid-up capital is ₹ 9.70 M.

  • Currently 4 directors are associated with Bengene Life Sciences Private Limited.

    • Senthiladipan Venkatachalam
    • Perumal Shanmugam
    • Dhanabal Lakshmanan
    • Ponniah Saravanaperumal
  • As per Ministry of Corporate Affairs (Mca), the registered address of Bengene Life Sciences Private Limited is R.S. No: 239/2 Mettupalayam - Manaveli Road Poothurai Village Vanur Taluk Villupur, Am, Villupuram, Tamil Nadu, India, 605111.

  • The corporate identification number (CIN) of Bengene Life Sciences Private Limited is U24290TN2019PTC127701 and the company number is 127701 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Bengene Life Sciences Private Limited is https://www.bengene.in

  • According to the financial reports for the fiscal year 2023, the revenue trend for Bengene Life Sciences Private Limited has fallen by -33.27%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Bengene Life Sciences Private Limited has experienced an upsurge of 34.79%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Bengene Life Sciences Private Limited amount to ₹ 1.45 Cr.

  • The most recent Balance Sheet for Bengene Life Sciences Private Limited was filed with the ROC on 31 Mar 2023.